Joben Bio-Medical Co Ltd is a Taiwan-based company mainly engaged in the development and sale of new plant medicines, local Chinese herbal medicines, health foods and medical beauty products. The Company develops JBM-TC4 plant new drug, which has been patented, used to provide raw materials for cancer treatment drugs.

Employees

Sector

Biotechnology & Medical Research

More about the company

End-of-day quote Taipei Exchange 18/10/2019			5-day change	1st Jan Change
10.50 ^TWD	+0.96%		+8.81%	-

13/08/19	Joben Bio-Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019	CI
15/04/19	Joben Bio-Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018	CI

Market Cap	641M 20.27B 551M 519M 474M 886M 60.5B 889M 6.13B 2.38B 31.04B 2.41B 2.35B 99.99B	P/E 2017	53.5x	P/E 2018	-22.8x
Enterprise Value	867M 27.45B 746M 702M 642M 1.2B 81.9B 1.2B 8.3B 3.22B 42.02B 3.26B 3.19B 135B	EV / Sales 2017	5.87x	EV / Sales 2018	15.8x
Free-Float	82.63%	Yield 2017	0.07%	Yield 2018	-

13/08/19	Joben Bio-Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019	CI
15/04/19	Joben Bio-Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018	CI

Director	Title	Age	Since
Wen Tien Huang CHM	Chairman	-	19/05/2010
Man Hsia Chia BRD	Director/Board Member	-	19/05/2010
Chao Yuan Kuo BRD	Director/Board Member	-	23/06/2011

JBM Share Price

Stocks

4193

TW0004193008

Biotechnology & Medical Research

Valuation : JBM

Latest news : JBM

Quotes and Performance

Managers and Directors : JBM

Other Biotechnology & Medical Research

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
JBM	+0.96%	+8.81%	-	-	21.03M
LONZA GROUP AG	-2.54%	-2.84%	-1.90%	+14.52%	50.35B
REVOLUTION MEDICINES, INC.	-1.15%	+0.51%	+436.46%	+520.21%	45.2B
IQVIA HOLDINGS INC.	-1.78%	+2.24%	+45.38%	+21.16%	44.71B
BEONE MEDICINES AG	-1.13%	-2.39%	+12.31%	+74.75%	41.24B
CELLTRION, INC.	+0.53%	-1.67%	+15.16%	+49.88%	33.08B
ASCENDIS PHARMA A/S	-0.35%	+8.94%	-	-	17.81B
MEDPACE HOLDINGS, INC.	-0.27%	-1.32%	+22.88%	+123.58%	16.56B
EUROFINS SCIENTIFIC SE	-1.01%	+0.50%	+15.83%	+27.98%	14.82B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.50%	-0.90%	+77.97%	+41.40%	14B
Average	-0.84%	+0.89%	+78.01%	+109.18%	27.78B
Weighted average by Cap.	-1.24%	-0.46%	+93.76%	+126.80%

	2017	2018
Net sales	554M 17.53B 477M 449M 410M 767M 52.31B 769M 5.3B 2.06B 26.84B 2.08B 2.04B 86.46B	192M 6.09B 166M 156M 142M 266M 18.17B 267M 1.84B 714M 9.32B 723M 707M 30.03B
Net income	60.66M 1.92B 52.2M 49.11M 44.86M 83.92M 5.73B 84.15M 580M 225M 2.94B 228M 223M 9.47B	-123M -3.9B -106M -99.85M -91.21M -171M -11.64B -171M -1.18B -458M -5.97B -463M -453M -19.25B
Net Debt	2.35M 74.32M 2.02M 1.9M 1.74M 3.25M 222M 3.26M 22.47M 8.72M 114M 8.82M 8.63M 367M	227M 7.17B 195M 184M 168M 314M 21.41B 315M 2.17B 842M 10.98B 851M 833M 35.38B